Skip to main content

Table 8 Survival analysis of three treatments on four BIC subtypes and three GBM subtypes

From: Integrative subspace clustering by common and specific decomposition for applications on cancer subtype identification

Treatment

All

Subtype1

Subtype2

Subtype3

Subtype4

Cytoxan(BIC)

3.3e-02

6.1e-01

4.5e-02

4.83e-01

5.01e-01

Adriamycin(BIC)

1.3e-02

2.77e-01

3.2e-02

8.21e-01

2.66e-01

Temozolomide(GBM)

3.6e-02

2.0e-02

9.18e-01

3.88e-01

——

  1. The treatment can significantly improve treatment outcomes in the subtype of p-value in boldface
Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us